Tm Bioscience biomarker collaboration
This article was originally published in The Gray Sheet
Executive Summary
Tm Bioscience is collaborating with Medco Health Solutions and the Mayo Clinic to study biomarkers that will help inform individual dosing of warfarin, a blood thinner. The study is slated to enroll more than 1,000 patients this year. Medco, the largest U.S. pharmacy benefits management firm, and Mayo Collaborative Services will evaluate the genetic test results derived from Tm's Tag-It reagents for genetic mutations P450-2C9 and others. Tm Bioscience was acquired by Luminex Dec. 14 (1"The Gray Sheet" Dec. 18, 2006, p. 16)...